1. Home
  2. PCRX vs HDL Comparison

PCRX vs HDL Comparison

Compare PCRX & HDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$26.23

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

HDL

SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares

HOLD

Current Price

$17.20

Market Cap

1.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
HDL
Founded
2006
2016
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2011
2024

Fundamental Metrics

Financial Performance
Metric
PCRX
HDL
Price
$26.23
$17.20
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$32.86
N/A
AVG Volume (30 Days)
723.2K
2.3K
Earning Date
11-06-2025
11-26-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.47
0.04
Revenue
$716,791,000.00
$820,865,000.00
Revenue This Year
$6.24
$11.19
Revenue Next Year
$9.53
$13.37
P/E Ratio
$55.78
$438.76
Revenue Growth
3.14
8.02
52 Week Low
$18.17
$16.30
52 Week High
$27.64
$30.00

Technical Indicators

Market Signals
Indicator
PCRX
HDL
Relative Strength Index (RSI) 67.86 45.04
Support Level $25.17 $17.00
Resistance Level $24.81 $17.49
Average True Range (ATR) 0.96 0.27
MACD 0.26 -0.03
Stochastic Oscillator 76.49 30.67

Price Performance

Historical Comparison
PCRX
HDL

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares

Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan. Its mission is to become a world-wide integrated restaurant group, build the world's Chinese cuisine brand, and promote Chinese culinary heritage world-wide.

Share on Social Networks: